Quick Reference Guide
glycaemic control in the short and medium term. A Advise all people who smoke to stop and offer support to help facilitate this to minimise cardiovascular and general health risks. Offer intensive management plus pharmacological therapies to people with diabetes who wish to stop smoking.
Guide, Management, Reference, Quick, Glycaemic, Pharmacological, Quick reference guide
Download Quick Reference Guide
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
SIGN 145 • Assessment, diagnosis and …
www.sign.ac.ukSIGN 145 • Assessment, diagnosis and interventions for autism spectrum disorders A national clinical guideline June 2016
Assessment, Interventions, Diagnosis, 145 assessment, Diagnosis and, Diagnosis and interventions for
A national clinical guideline
www.sign.ac.ukScottish Intercollegiate Guidelines Network Management of diabetes A national clinical guideline March 2010
Guidelines, Management, Clinical, Diabetes, Clinical guidelines, Management of diabetes
A national clinical guideline
www.sign.ac.ukScottish Intercollegiate Guidelines Network Management of chronic venous leg ulcers A national clinical guideline This guideline is dedicated to the memory
SIGN 149 • Risk estimation and the prevention of ...
www.sign.ac.ukSIGN 149 • Risk estimation and the prevention of cardiovascular disease Quick Reference Guide July 2017 Evidence
Risks, Disease, Prevention, Cardiovascular, The prevention of cardiovascular disease
SIGN 88 • Management of suspected bacterial …
www.sign.ac.ukSIGN 88 • Management of suspected bacterial urinary tract infection in adults A national clinical guideline Updated July 2012
Bacterial, Management, Adults, Suspected, Urinary, 88 management of suspected bacterial, 88 management of suspected bacterial urinary, In adults
Part of NHS Quality Improvement Scotland
www.sign.ac.ukScottish Intercollegiate Guidelines Network Part of NHS Quality Improvement Scotland SIGN Management of Obesity A national clinical guideline February 2010
SIGN 147 • Management of chronic heart failure
www.sign.ac.ukSIGN 147 • Management of chronic heart failure A national clinical guideline March 2016 Evidence www.healthcareimprovementscotland.org
50 SIGN 50
www.sign.ac.uk1 1 INTRODUCTION Meeting the agree appraisal criteria SIGN methodology complies with the criteria used by the AGREE (Appraisal of Guidelines for
Part of NHS Quality Improvement Scotland
www.sign.ac.ukScottish Intercollegiate Guidelines Network Part of NHS Quality Improvement Scotland SIGN Management of hip fracture in older people A national clinical guideline
Related documents
Diabetes and Mental Health
www.diabetes.org.ukpharmacological interventions for depression in patients with ... reviews of consultation and self-management interventions. Primary Health Care Research & Development 10(3); 210-222. 12 12 ... interventions to improve glycaemic control in patients with type 1 diabetes: systematic review and meta-analysis of ...
Guideline: Gestational Diabetes Mellitus (GDM)
www.health.qld.gov.auongoing management • Advising consumers of their choices in an environment that is culturally appropriate and which enables comfortable and confidential discussion. This includes the use of interpreter services where necessary • Ensuring informed consent is …
Guidelines, Management, Diabetes, Mellitus, Gestational, Gestational diabetes mellitus
Diagnosis and Treatment of Gestational Diabetes
www.rcog.org.ukglycaemic targets with treatment had the lowest risk of complications. 12 The lowest risk of complications – including birthweight greater than 4 kg, prematurity, pre-eclampsia and neonatal hypoglycaemia – occurred with fasting capillary glucose levels ≤4.9 mmol/l and 2-hour postprandial glucose 5.9–6.4 mmol/l.
Diagnosis and management of Type 2 Diabetes (T2DM) in ...
www.england.nhs.uk5. Management Goals for T2DM: 24 1. Lifestyle modification 2. Normalisation of glycaemic control 3. Emotional well being 4. Education for diabetes self-management 5. Control of comorbidities (including hypertension, dyslipidaemia, nephropathy, sleep disorders and hepatic steatosis) 6. Smoking cessation 6. Management of T2DM:
SIGN 154 • Pharmacological management of glycaemic …
www.sign.ac.ukPharmacological management of glycaemic control in people with type 2 diabetes | 1 1 Introduction 1.1 THE NEED FOR A GUIDELINE The immediate purpose of lowering blood glucose in people with type 2 diabetes is to provide relief from symptoms (thirst, polyuria, nocturia, and blurred vision). Thereafter, the aim is to prevent microvascular
Management, Control, Glycaemic, Pharmacological, Pharmacological management of glycaemic control, Pharmacological management of glycaemic
Cardiovascular Disease Risk Assessment and Management …
www.health.govt.nzCVD risk assessment and management is a recommended component of the annual diabetes ... main disease variables (diabetes duration, renal disease, glycaemic control) apply as for type 2 diabetes. CVD risks for this group are substantially higher than for people with type 2 ... it is reasonable to consider pharmacological treatment of
Assessment, Management, Risks, Disease, Cardiovascular, Glycaemic, Pharmacological, Cardiovascular disease risk assessment and management
Management of Neuropathic Pain for Adults in Primary Care
www.nottsapc.nhs.ukPharmacological Management Non •See page 4 for information regarding realistic expectation of pharmacological management. •Ensure adequate doses are trialled for a long enough time before moving to the next step. Do not continue ineffective treatment i.e. use “short sequential trials “or “one medication at a time”.
ssociation of Children’s Diabetes Clinicians
www.a-c-d-c.orgGlycaemic control improves microvascular risk. However, the increased risk of a major cardiovascular event (MACE) in adults ... diabetes management is in primary care and specialist adult clinics, neither of which has expertise ... and pharmacological treatments.
Educating Representing Supporting
abcd.careInadequate glycaemic control in spite of optimal current treatment and / or at high risk of cardiac and renal adverse outcome eGFR >60 ml/min/1.73 m2 (a lower cut off may be recommended for an individual by a diabetes specialist) BMI >27 kg/m2 although diabetes specialists may use them in people with a lower BMI for potential cardiac or renal ...